TESTIMONIALS FROM THE HEALTHCARE INDUSTRY
THE SURVEY MADE US DISCOVER UNEXPECTED MARKET POTENTIAL
Charlotte Ungerth, Head of Aesthetics Business Unit Nordics at Galderma and previously strategically responsible for the business area on a global level have experience from aesthetics for over seven years and worked with several projects together with Opticom. The reason Galderma once again turned to Opticom for market insights this time was for a new brand Restylane Eyelight. Read how this project made Galderma discover unexpected market potential.
FAST AND SOLID AD TESTING RESULTS FROM SELECTED TARGET GROUPS IS A WORTHWHILE INVESTMENT
Testing marketing material before it goes into production and is launched is becoming increasingly important, especially among leading pharmaceutical companies. Anna Burrows, Account Director at Up There Everywhere, a Stockholm-based global digital advertising agency handling marketing campaigns for Galderma, specializing in dermatological injectables and skin care products, believes that this is a model for the future.
In less than 3 weeks, Opticom and Up There Everywhere, organized advertising concept tests with hundreds of consumers and several treating doctors in different countries. The results from the market research were clear and with some amendments, based on respondent feedback, two ad concepts got the green light. Anna Burrow concludes that the main benefit of the market research project was getting solid answers from the right target audience really fast.
LONG LASTING MARKET RESEARCH BENEFITS!
In brief - Michael McGowan is Director of Market Intelligence at SHL Medical and based in Zug, Switzerland. The company is a world-leading designer, developer, and manufacturer of drug delivery solutions such as autoinjectors for the pharma industry.
Michael is responsible for generating primary market data and also using secondary data such as quantitative market information and says: “When I joined the company back in 2016, we had some gaps in our market knowledge and a number of open questions in terms of what customer expectations. Likewise we felt it was an important point in time to better understand what our customers thought of how SHL was meeting their needs and performing on a daily basis”
With these objectives in mind, the company decided to conduct a worldwide Voice of Customer (VoC) survey to get SHL’s customers’ views on how their markets and business prospects were developing.
BEYOND THE PILL! WITHOUT E-HEALTH - VISION 2025 TREND WATCHING, WE HAVE NO CLUE OF DEVELOPMENT!
In brief - As a trade association, it is important to get insights, to be relevant and stay up to date in our service offer to our 90 members Life Science Companies and a continuous dialogue with the Swedish Ministry of Industry. But also, in contacts with authorities, organizations, and decision makers, assisting and informing them on questions vital to the industry. The organization also represents Sweden in the ethical work of international trade organizations
This project; e-health vision 2025, is a way for us to map how the pharmaceutical industry is working with digitalization and the development of e-health, getting a picture of how their work is developing and where their interests and focus lie.
The material is an excellent source of information for all involved, it serves as inspiration for our Life Science member companies and encourages fruitful discussions. So this project really fulfils many purposes for our organization. We did the first survey in 2018, continued in 2019 and at the moment, the survey for 2020 is ongoing.
SUSTAINABILITY MORE IMPORTANT THAN EVER AFTER THE COVID 19 OUTBREAK!
Galderma is the world’s largest independent global dermatology company, with presence in over 100 countries. The company was the first in the world introducing hyaluronic acid fillers for aesthetic injections and is driven by medical research to help consumers achieve the desired natural improved look they want. Galderma’s overall aim is to continue to deliver a comprehensive portfolio of recognized products and services, trusted by both healthcare providers and consumers.
At the moment, Peter Herte, Global Brand Manager at Galderma Global, is working in a sustainability project together with Opticom, aiming at getting better market insights about this very current topic, increasingly affecting our global society on so many levels.
LUPIN: VALUABLE INSIGHTS READY TO ACT UPON!
Pietro Crovetto, VP Global Inhalation Strategy at Lupin Pharmaceuticals with vast experience from the international pharmaceutical industry at various prominent positions within commerce, marketing, strategy, and business development, for a variety of companies including Novartis, Chiesi, ALK Abelló and Teva Pharmaceuticals. Pietro has been a client to Opticom for over 10 years, both at previous positions and now, working for Lupin. He gives the background to his experiences with Opticom International Research, focusing on the latest Lupin project Opticom conducted, that he was personally involved in.
PFIZER: OUR MISSION WAS TO END THE TRANS - AND WE DID!
Francesco De Rosa, with vast experience from the international pharma industry at various prominent positions within sales, brand and business managing, gives the background to one of his first experiences with Opticom International Research: “At the time, I had taken over a very important Pfizer brand with a five-year legacy of declining market shares and I needed to get a 360 degree understanding of the decision-making process within the growth hormone therapy area” he explains and continues: “My scope was clear: bend the trend!”.
CARIS LIFE SCIENCES: FUTURE LABS VALUABLE FOR EVERYONE INVOLVED
Many believe personalised medicine is the future for health care. Caris, a pioneer in this field, specialised in personalised cancer diagnostics, discovered that although many agree that this is the future, it is hard to present the service and discuss how this future would fit today’s practices. To overcome this challenge and discuss the whole issue as a common challenge that needs involvement from different stakeholders in health care, Caris engaged Opticom to conduct Future Labs in a number of cities across Sweden.
SOBI: A GLOBAL PLAYER IS NEEDED TO GET FULL INSIGHT ACROSS INTERNATIONAL MARKETS
The international width that Opticom provides is very valuable for a company like Sobi, as we are working globally, offering products on some 50 markets worldwide. That is when you need a true global player to co-operate with, a local market research company present in just one or two markets have more difficulty providing us what we need” says Charlotte Ungerth, Global Brand Director at Sobi (Swedish Orphan Biovitrum).
NEUROLOGY CLINIC: OPTICOM AS AN ADVISING PARTNER FOR START UP AT SOPHIAHEMMET
The neurology field is facing increasing demands; such as a fast-growing population, increase of ageing patients and major advances in neuroscience. Thus, wide changes are needed in order to meet the care challenges for patients with neurological diseases. In Stockholm, a new private concept is now being shaped; providing care and serving as a complement to public neurology care. Looking for a partner in market analysis and strategic consulting; Neurology Clinic Stockholm turned to Opticom as an advising partner in the start up of a neurology specialist centre, which will be moving into new facilities at Sophiahemmet during the autumn of 2012.
ABBOTT DIABETES CARE: OPTICOM AS A STRATEGIC PARTNER
Fierce competition between suppliers characterise the market for blood glucose meters with the additional challenge that this market is strictly regulated by public procurement. All blood glucose meter suppliers are fully dependent on getting their meters on tender in as many counties as possible. A customer can only obtain disposables (test strips) for a meter that is currently on tender and which meters are selected and available to customers is under constant change. Creating loyal customers under those conditions is quite a challenge. Abbott Diabetes Care has selected Opticom as a strategic partner in its strive for success.